17 results
8-K
EX-3.2
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
of Directors, he or she shall perform all duties and have all powers which are commonly incident to the position of Chair of the Board or which are delegated … the duties incident to that position. The Chief Executive Officer shall, in the absence of the Chair of the Board, or if a Chair of the Board shall not have
8-K
EX-1.1
1vkcwhwazgq07a1 x1
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
8-K
EX-2.1
skh7hvt
10 Aug 21
Maravai Lifesciences Reports Second Quarter Financial Results and Updates 2021 Financial Guidance
4:18pm
8-K
EX-4.1
034 kieqb1
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
DRS/A
EX-10.18
rajszoe
14 Oct 20
Draft registration statement (amended)
12:00am
S-1
EX-10.18
bbihybk0po
29 Oct 20
IPO registration
5:04pm
8-K
EX-10.3
mbtjo7i9
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
- Prev
- 1
- Next